Company Updates
Innovative SaaS Platform miiGroup Announces 20% WoW Growth and a Closing Pre-Series A
miiGroup CEO and Founder, Jason Knight, recently provided the latest update on the company’s current activities as well as plans for the future announced.
Actinogen Medical Appoints Dr Geoff Brooke as Chairman
Actinogen Medical is pleased to announce that is has appointed healthcare industry and venture capital veteran, Dr Geoff Brooke, as Chairman, effective 1st March.
Space Age Solar Technology by RayGen, Showcased for Renewables Investors
RayGen is an Australian-based solar technology business. The Company’s mission is to use innovative technological solutions to provide, cheap, clean and renewable energy for people all over the world.
Drivemycar Signs Strategic Agreement With $1bn Vehicle Leasing Giant Orix
Collaborate is pleased to announce that its DriveMyCar has signed a strategic agreement with ORIX for vehicles to be rented through the DriveMyCar platform to private and corporate rental customers.
Folkestone Reports Half Year Profits of $3.2 Million
Folkestone (ASX:FLK) today announced a statutory net profit after tax for the six months ended 31 December 2016 of $3.19 million, an increase of 6.0 per cent over HY16.
Tesserent Debt Free with Cash Balance of $1.91m
Managed cyber security specialist Tesserent Limited (ASX:TNT) is pleased to provide its Half Yearly Results Report for the period ended 31 December 2016.
Real Estate Investar carries Strong Growth in Revenue with its First HY2017
Real Estate Investar, a leading data driven provider of investment property analysis, tracking and transaction services to Australian and NZ property investors, has released its HY results.
Martin Aircraft Limited announces supply of Series 1 Jetpacks
Martin Aircraft Limited (ASX:MJP) is pleased to announce that it has entered into an agreement today with Shenzhen KuangChi Dream Technology Company Limited
Imugene Announces New Strategic Partnership with the Baker Institute
New strategic partnerships with the Baker Institute investigating the opportunities for small molecules in immune-oncology.
Backed By Leading Investment Groups and Family Offices
